LETTER
solution of the appropriate 3-aryl-1-(2-hydroxyphenyl)-
Synthesis of 5-Arylbenzo[c]xanthones
563
73 mg (70%); 4d: 66 mg (62%); 4e: 55 mg (50%); 4f: 51 mg
(45%)]. The reaction of 3-bromoflavone 2a (0.296 mmol)
with styrene 3b (1.48 mmol), under the same reaction
conditions, yielded 3-(3,4-dimethoxystyryl)flavone 4g (72
mg, 63%)
propan-1,3-dione 1a–f (1.63 mmol). The reaction mixture
was stirred at room temperature for 24–48 h. After that
period, the reaction mixture was poured into a mixture of ice
(10 g) and water (30 mL), stirred for 30 min, and extracted
with chloroform (3 × 20 mL). The combined extracts were
dried over sodium sulfate and evaporated to dryness. The
obtained residue was purified by TLC (CH2Cl2–light
petroleum, 9:1). After solvent evaporation, the obtained
residue was recrystallised from ethanol giving 3-
bromoflavones 2a–f [2a: 196 mg (40%); 2b: 226 mg (44%);
2c: 343 mg (45%); 2d: 230 mg (42%); 2e: 237 mg (42%); 2f:
188 mg (32%)]
(24) (E)-3-(3,4-Dimethoxystyryl)flavone (4g): Yellow solid;
mp 158–160 °C. 1H NMR (300.13 MHz, CDCl3): d = 3.86
(s, 3 H, 4¢¢-OCH3), 3.88 (s, 3 H, 3¢¢-OCH3), 6.72 (d,
J = 16.2 Hz, 1 H, H-a), 6.82 (d, J = 8.1 Hz, 1 H, H-5¢¢), 6.93
(d, J = 1.6 Hz, 1 H, H-2¢¢), 6.95 (d, J = 9.2 Hz, 1 H, H-6¢¢),
7.44 (ddd, J = 1.7, 7.1, 8.3 Hz, 1 H, H-6), 7.51 (dd, J = 1.7,
8.3 Hz, 1 H, H-8), 7.53–7.58 (m, 3 H, H-3¢,4¢,5¢), 7.69 (ddd,
J = 1.7, 7.1, 8.3 Hz, 1 H, H-7), 7.76–7.79 (m, 2 H, H-2¢,6¢),
7.95 (d, J = 16.2 Hz, 1 H, H-b), 8.33 (dd, J = 1.7, 8.3 Hz,
1 H, H-5). 13C NMR (75.47 MHz, CDCl3): d = 55.8 (4¢¢-
OCH3), 55.9 (3¢¢-OCH3), 109.3 (C-2¢¢), 111.2 (C-5¢¢), 117.8
(C-3), 117.9 (C-8), 118.3 (C-a), 119.3 (C-6¢¢), 123.5 (C-10),
125.1 (C-6), 126.3 (C-5), 128.4 (C-3¢,5¢), 129.9 (C-2¢,6¢),
130.6 (C-4¢), 131.3 (C-1¢¢), 133.3 (C-1¢), 133.4 (C-7), 134.1
(C-b), 148.8 (C-3¢¢), 148.9 (C-4¢¢), 155.4 (C-9), 162.5 (C-2),
177.6 (C-4). MS (ESI+): m/z (%) = 385 (100) [M + H]+, 407
(20) [M + Na]+. Anal. Calcd for C25H20O4 (384.42): C,
78.11; H, 5.24. Found: C, 78.15; H, 5.31
(15) 3-Bromo-4-methylflavone (2b): Yellow solid; mp 146–
148 °C. 1H NMR (300.13 MHz, CDCl3): d = 2.47 (s, 3 H, 4¢-
CH3), 7.34 (d, J = 8.2 Hz, 2 H, H-3¢,5¢), 7.44 (br dd, J = 7.1,
8.3 Hz, 1 H, H-6), 7.51 (br d, J = 8.3 Hz, 1 H, H-8), 7.72
(ddd, J = 1.7, 7.1, 8.1 Hz, 1 H, H-7), 7.78 (d, J = 8.2 Hz,
2 H, H-2¢,6¢), 8.31 (dd, J = 1.7, 8.3 Hz, 1 H, H-5). 13C NMR
(75.47 MHz, CDCl3): d = 21.6 (4¢-CH3), 108.9 (C-3), 117.8
(C-8), 121.8 (C-10), 125.6 (C-6), 126.5 (C-5), 129.0 (C-
3¢,5¢), 129.3 (C-2¢,6¢), 133.7 (C-1¢), 134.1 (C-7), 141.7 (C-
4¢), 155.6 (C-9), 162.1 (C-2), 173.2 (C-4). MS (ESI+): m/z
(%) = 315 (100) ([M + H]+, 79Br), 317 (90) ([M + H]+, 81Br),
337 (87) ([M + Na]+, 79Br), 339 (83) ([M + Na]+, 81Br). Anal.
Calcd for C16H11O2Br (315.16): C, 60.98; H, 3.52. Found: C,
60.88; H, 3.52
(16) Joo, Y. H.; Kim, J. K. Synth. Commun. 1998, 28, 4287.
(17) Miyake, H.; Nishino, S.; Nishimura, A.; Sasaki, M. Chem.
Lett. 2007, 36, 522.
(18) Rinker, B.; Schnakenburg, G.; Nieger, M.; Waldvogel, S. R.
Synthesis 2011, 0593.
(19) Rocha D. H. A., Pinto D. C. G. A., Silva A. M. S., Patonay
T., Cavaleiro J. A. S.; unpublished results
(20) (a) Fitzmaurice, R. J.; Etheridge, Z. C.; Jumel, E.; Woolfson,
D. N.; Caddick, S. Chem. Commun. 2006, 4814.
(25) Silva, V. L. M.; Silva, A. M. S.; Cavaleiro, J. A. S. Synlett
2010, 2565.
(26) Yamashita, S. Bull. Chem. Soc. Jpn. 1961, 34, 487.
(27) 5-Phenyl-7H-benzo[c]xanthen-7-one (5a): Mp 197–
198 °C. 1H NMR (300.13 MHz, CDCl3): d = 7.47 (br dd,
J = 7.0, 8.0 Hz, 1 H, H-9), 7.47–7.50 (m, 1 H, H-4¢), 7.52–
7.54 (m, 4 H, H-2¢,3¢,5¢,6¢), 7.67 (ddd, J = 1.5, 6.2, 8.0 Hz,
1 H, H-3), 7.74 (ddd, J = 1.5, 6.2, 8.0 Hz, 1 H, H-2), 7.75 (br
d, J = 8.0 Hz, 1 H, H-11), 7.81 (ddd, J = 1.3, 7.0, 8.0 Hz,
1 H, H-10), 8.02 (dd, J = 1.5, 8.0 Hz, 1 H, H-4), 8.24 (s, 1 H,
H-6), 8.44 (dd, J = 1.3, 8.0 Hz, 1 H, H-8), 8.81 (dd, J = 1.5,
8.0 Hz, 1 H, H-1). 13C NMR (75.47 MHz, CDCl3): d = 117.1
(C-6a), 118.1 (C-11), 121.9 (C-6), 122.5 (C-7a), 123.1 (C-1),
124.4 (C-12b), 124.5 (C-9), 126.6 (C-2), 126.7 (C-4), 126.8
(C-8), 127.6 (C-4¢), 128.4 (C-2¢,6¢), 129.6 (C-3), 130.1 (C-
3¢,5¢), 132.1 (C-10), 133.7 (C-4a), 134.4 (C-5), 136.6 (C-1¢),
155.8 (C-12a), 168.4 (C-11a), 177.2 (C-7). MS (ESI+): m/z
(%) = 323 (100) [M + H]+, 345 (22) [M + Na]+. MS (EI+):
m/z calcd for C23H14O2: 322.0994; found: 322.0995
(b) Polshettiwar, V.; Varma, R. S. Acc. Chem. Res. 2008, 41,
629.
(21) (a) Kappe, C. O. Angew. Chem. Int. Ed. 2004, 43, 6250.
(b) Kappe, C. O.; Dallinger, D. Nat. Drug Discovery 2006,
5, 51.
(22) (a) Jeffery, T. Tetrahedron Lett. 1985, 26, 2667. (b)Jeffery,
T. Synthesis 1987, 70. (c) Woodcock, S.; Branchaud, B. P.
Tetrahedron Lett. 2005, 46, 7213. (d) Pan, K.; Noël, S.;
Pinel, C.; Djakovitch, L. J. Organomet. Chem. 2008, 693,
2863.
(28) 5-Phenyl-5H-benzo[c]xanthen-7(6H)-one (6a): 1H NMR
(300.13 MHz, CDCl3): d = 3.24 (dd, J = 9.0, 16.5 Hz, 1 H,
H-6cis), 3.33 (dd, J = 7.3, 16.5 Hz, 1 H, H-6trans), 4.32 (dd,
J = 7.3, 9.0 Hz, 1 H, H-5), 7.06 (dd, J = 7.6 Hz, 1 H, H-2),
7.18–7.23 (m, 2 H, H- 3¢,5¢), 7.23–7.26 (m, 1 H, H-4), 7.27–
7.32 (m, 2 H, H-2¢,6¢), 7.38- 7.49 (m, 3 H, H-9,3,4¢), 7.59
(dd, J = 1.4, 8.3 Hz, 1 H, H-11), 7.69 (ddd, J = 1.4, 7.0,
8.3 Hz, 1 H, H-10), 8.09 (dd, J = 1.8, 7.6 Hz, 1 H, H-1), 8.24
(dd, J = 1.4, 8.3 Hz, 1 H, H-8). 13C NMR (75.47 MHz,
CDCl3): d = 27.2 (C-6), 43.1 (C-5), 115.4 (C-6a), 117.9 (C-
11), 123.6 (C-7a), 124.0 (C-1), 125.9 (C-8), 126.8 (C-4),
127.3 (C-4¢), 128.2 (C-3¢,5¢), 128.47 (C-12b), 128.5 (C-
2¢,6¢), 128.7 (C-2), 131.4 (C-3), 133.3 (C-10), 141.7 (C-1¢),
142.7 (C-4a), 155.6 (C-11a), 157.4 (C-12a), 177.2 (C-7). MS
(EI+): m/z calcd for C23H16O2: 324.1150; found: 324.1147
(29) Optimised procedure for the synthesis of 5-phenyl-7H-
benzo[c]xanthen-7-ones 5a–h: A mixture of the
(23) Optimised procedure for the synthesis of 3-styryl-
flavones 4a–g: A mixture of the appropriate 3-bromo-
flavone 2a–f (0.296 mmol), anhydrous K2CO3 (123 mg,
0.888 mmol), tetrabutylammonium bromide (TBAB; 238
mg, 0.740 mmol), palladium acetate (9.97 mg, 0.044 mmol)
and styrene 3a (0.170 mL, 1.48 mmol) in DMF (6 mL), was
poured into a two-necked flask equipped with a magnetic
stirring bar, fibre-optic temperature control, and reflux
condenser and placed under a nitrogen atmosphere. The
mixture was then irradiated in an Ethos SYNTH microwave
(Milestone Inc.) at constant power of 300 W from 5–10 min.
After that period, the reaction mixture was poured into a
mixture of ice (1 g) and water (10 mL) and extracted with
diethyl ether (3 × 10 mL). The organic layer was evaporated
to dryness and the obtained residue was taken in ethyl
acetate (10 mL) and washed with water (2 × 10 mL). The
organic layer was dried with anhydrous sodium sulfate,
evaporated and purified by column chromatography
(CHCl3–acetone, 9.6:0.4). After solvent evaporation, the
obtained residue was recrystallised from ethanol to give 3-
styrylflavones 4a–g [4a: 67 mg (70%); 4b: 68 mg (68%); 4c:
appropriate 3-styrylflavone 4a–g (0.15 mmol) and a
catalytic amount of I2 (10% mol) in 1,2,4-trichlorobenzene
(20 mL), was poured into a three-necked flask equipped with
a magnetic stirring bar, reflux condenser and a high-pressure
mercury UV lamp with 400 W power. The mixture was then
irradiated from 2 to 6 days. After that period, the reaction
mixture was poured into a silica gel column and eluted with
light petroleum to remove the excess of iodine and 1,2,4-
© Thieme Stuttgart · New York
Synlett 2012, 23, 559–564